HELMHOLTZ ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH has a total of 37 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2002. It filed its patents most often in Australia, Canada and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are BOEHRINGER INGELHEIM ESPANA, SALK INST BIOLOGICAL STUDIES and JEIL PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 16 | |
#2 | Canada | 7 | |
#3 | United States | 5 | |
#4 | China | 3 | |
#5 | Japan | 2 | |
#6 | Hong Kong | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Singapore | 1 | |
#9 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Fermentation | |
#5 | Heterocyclic compounds | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Climate change adaptation technologies | |
#8 | Peptides | |
#9 | Enzymes | |
#10 | Microbiology |
# | Name | Total Patents |
---|---|---|
#1 | Steinmetz Heinrich | 6 |
#2 | Morr Michael | 6 |
#3 | Hamed Mostafa | 5 |
#4 | Ebensen Thomas | 5 |
#5 | Herrmann Jennifer | 5 |
#6 | Muller Rolf | 5 |
#7 | Guzman Carlos A | 5 |
#8 | Hartmann Rolf | 4 |
#9 | Baumann Sascha | 4 |
#10 | Ferrer Manuel | 4 |
Publication | Filing date | Title |
---|---|---|
AU2016236187A1 | Inhibitors of Pseudomonas aeruginosa LecB | |
CN107001241A | New sporangiocyst bacterium acid amides | |
KR20150004830A | PHA-producing genetically engineered microorganisms | |
AU2011325439A1 | Methods and vectors for cell immortalisation | |
AU2003226777A1 | Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations |